Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05107414 · ClinicalTrials.gov registry record
Journey 2 Multi Center Kinematic Study
A clinical trial, sponsored by The University of Tennessee, Knoxville.
- Completed
- Registry status
- 201
- Enrollment target
NCT05107414: Completed study, sponsored by The University of Tennessee, Knoxville.
NCT05107414 is a clinical trial that has completed, run by The University of Tennessee, Knoxville. The registered enrollment target is 201 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05107414 has completed, sponsored by The University of Tennessee, Knoxville.
- COMPLETED
- Registry status
- 201 participants
- Enrollment target
Study Summary
The objective of this study is to determine and compare the in vivo kinematics and vibroarthrography (VAG) signals for subjects implanted with Journey II Bi-Cruciate Stabilized (BCS), CR (Cruciate Retaining), and Bi-Cruciate Retaining (XR) TKAs.
Primary Outcome
The condylar rollback of the medial condyle will be observed at a single instance in time. Higher rollback indicates more motion and improved kinematics. Participants will have previously undergone a total knee arthroplasty but data cannot be collected on their preoperative kinematics. Outcome will be measured in \[mm\].
Interventions
- DEVICE Total Knee Arthroplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2021-05-15 |
| Est. Completion | 2024-12-31 |
What the finished NCT05107414 record still lists
NCT05107414 is an observational study that tracks outcomes without assigning an intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Total Knee Arthroplasty is the first listed.
NCT05107414 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05107414 about?
NCT05107414 is a clinical study titled "Journey 2 Multi Center Kinematic Study". The objective of this study is to determine and compare the in vivo kinematics and vibroarthrography (VAG) signals for subjects implanted with Journey II Bi-Cruciate Stabilized (BCS), CR (Cruciate Retaining), and Bi-Cruciate Retaining (XR) TKAs.
What is the current status of trial NCT05107414?
This trial is currently completed. The enrollment target is 201 participants. The study started on 2021-05-15. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT05107414?
The interventions under investigation include: Total Knee Arthroplasty (DEVICE).
Who is sponsoring clinical trial NCT05107414?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI